Cargando…
Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms
INTRODUCTION: For many tumors, the overexpression of the chemokine receptor CXCR4 is associated with increased malignancy and poor patient outcomes. However, comprehensive data for neuroendocrine neoplasms of the lung are still lacking. METHODS: CXCR4 expression was evaluated in a panel of bronchopu...
Autores principales: | Kaemmerer, Daniel, Reimann, Christiane, Specht, Elisa, Wirtz, Ralph M., Sayeg, Manal, Baum, Richard P., Schulz, Stefan, Lupp, Amelie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413658/ https://www.ncbi.nlm.nih.gov/pubmed/25671300 |
Ejemplares similares
-
Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin
por: Mai, Rebekka, et al.
Publicado: (2019) -
Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy
por: Kaemmerer, Daniel, et al.
Publicado: (2015) -
Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects
por: Neubauer, Elisa, et al.
Publicado: (2016) -
Prognostic value of PD-L1 expression in bronchopulmonary neuroendocrine tumours
por: Rösner, Erik, et al.
Publicado: (2021) -
Reassessment of somatostatin receptor SST4 expression in bronchopulmonary and gastroenteropancreatic neuroendocrine neoplasms using the novel rabbit monoclonal anti-human SST4 antibody 7H49L61
por: Ehms, Blanca, et al.
Publicado: (2022)